Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    L-Histidine

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 72Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    26/09/2024 Ajinomoto Company
    Japan
    		 Ajinomoto Health & Nutrition North America, Inc. 224MF10006 Japanese Pharmacopoeia L-Histidine (for manufacturing o... 2012-01-18 2012-01-18 4020 Ajinomoto Drive Raleigh, North Carolina 27610, USA
    26/09/2024 Kyowa Hakko Bio
    Japan
    		 Kyowa Hakko Bio Co., Ltd. 224MF10011 Japanese Pharmacopoeia L-Histidine (for manufacturing o... 2012-01-18 2012-01-18 1-6-1 Otemachi, Chiyoda-ku, Tokyo